Camphor/menthol/methyl salicylate/tartrazine

LPA1 antagonist 1 is a highly selective Lysophosphatidic Acid receptor-1 (LPA1) antagonist (IC50: 25 nM).

LPA1 antagonist 1 is a highly selective Lysophosphatidic Acid receptor-1 (LPA1) antagonist (IC50: 25 nM).

LPA1 antagonist 1 is a highly selective Lysophosphatidic Acid receptor-1 (LPA1) antagonist (IC50: 25 nM).

A lipophilic and non-hydrolyzable cAMP analog that acts as a site-selective inhibitor of PKA type I and II, with preference towards site A of type I and site B of type II.

Application Takasago Ligands and Complexes for Asymmetric Reactions Catalyst for: Noyori-type enantioselective ketone hydrogenation Enantioselective and asymmetric hydrogenation of ketones Legal Information Sold in collaboration with Takasago for

DescriptionEvonik Noblyst®P3059 5% Ru is a ruthenium on carbon catalyst. It has been shown to be effective in the following reactions:hydrogenation of aldehydes and ketoneshydrogenation of sugarshydrogenation of carboxylic acids, esters, and

α7 nAChR partial agonist.

α7 nAChR partial agonist.

α7 nAChR partial agonist.

α7 nAChR partial agonist.

α7 nAChR partial agonist.

S-acetyl-PEG2-t-butyl ester is a PEG derivative containing a sulfur acetyl group and a t-butyl ester. The sulfur acetyl group can be deprotected to form a thiol group.